Sponsor
Therapeutic Concepts
Clinical research sponsor
Clinical trials
4 shownOpen Label, Pilot Study of Darunavir Boosted by Cobicistat in Combination With Rilpivirine to Treat HIV+ Naïve SubjectsNCT02404233 · lead sponsor · 2015-03-01
UNKNOWNNucleoside Switch Pilot for Virologically Controlled HIV Subjects With Decreasing CD4 Cells Who Have Received TDF-based ARV TherapyNCT01608269 · lead sponsor · 2010-11-01
COMPLETEDA Pilot Study of Kaletra and Intelence Tablets in Naive SubjectsNCT01045369 · lead sponsor · 2010-01-01
COMPLETEDStudy of the 48-Week Virologic and Immunologic Response to Lopinavir/Ritonavir (Kaletra) in HIV Positive Adult PatientsNCT00116636 · lead sponsor · 2005-06-01
COMPLETEDSponsor roles
lead sponsor4
How to interpret this record
CureCurrent links normalized diseases, medicines, registry study labels, sponsors and research sites. A link is not the same as a finding of clinical effectiveness. Our research guides explain how to compare studies, decode RxNorm identities, and avoid over-interpreting site and trial counts. See the published database coverage for mapping completeness.
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.